Rosetta Genomics Ltd. Forms 3, 4 and 5: Corporate Securities (Bonds and Notes)
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-03-14: Reporting owner SABBY MANAGEMENT, LLC | Sabby Healthcare Master Fund, Ltd.; Form 3; Security $598,000 Convertible Debenture due February 23, 2047; Transaction Holding.
- 2018-03-14: Reporting owner SABBY MANAGEMENT, LLC | Sabby Healthcare Master Fund, Ltd.; Form 3; Security $1,885,000 Convertible Debenture due October, 2047; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-03-14 holding as of filing | SABBY MANAGEMENT, LLC | Sabby Healthcare Master Fund, Ltd. 10% Owner | 10% Owner | 3 | $598,000 Convertible Debenture due February 23, 2047 Derivative · Indirect · See Footnotes | Holding | $0.92 exercise price | 2018-03-14 | ||
| 2018-03-14 holding as of filing | SABBY MANAGEMENT, LLC | Sabby Healthcare Master Fund, Ltd. 10% Owner | 10% Owner | 3 | $1,885,000 Convertible Debenture due October, 2047 Derivative · Indirect · See Footnotes | Holding | $0.92 exercise price | 2018-03-14 |